Keyphrases
Nitrate
100%
Congestive Heart Failure
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Hydralazine
37%
Heart Failure
25%
Stroke Volume
25%
Canine Model
12%
Long-term Benefit
12%
Exercise Tolerance
12%
Symptom Relief
12%
Mechanism of Action
12%
Vascular Smooth muscle Cells
12%
Multicenter Trial
12%
Left Ventricular Dysfunction
12%
Exercise Capacity
12%
Response to Therapy
12%
Cardiac Remodeling
12%
Large Arteries
12%
Ejection Fraction
12%
Treatment Goals
12%
Long-term Survival
12%
Modified Windkessel Model
12%
Arterial Compliance
12%
Survival Benefit
12%
Filling Pressure
12%
Myocardial Remodeling
12%
Hemodynamic Improvement
12%
Left Ventricular Filling Pressure
12%
Venous Circulation
12%
Norepinephrine Levels
12%
Medicine and Dentistry
Congestive Heart Failure
100%
ACE Inhibitor
100%
Nitric Acid Derivative
100%
Hydralazine
42%
Hemodynamic
28%
Stroke Volume
28%
Vascular Smooth Muscle
14%
Heart Left Ventricle Failure
14%
Noradrenalin
14%
Ejection Fraction
14%
Heart Ventricle Remodeling
14%
Exercise Tolerance
14%
Artery Compliance
14%
Long Term Survival
14%
Venous Circulation
14%
Heart Left Ventricle Filling Pressure
14%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Congestive Heart Failure
100%
Nitric Acid Derivative
100%
Hydralazine
42%
Cerebrovascular Accident
28%
Canine Model
14%
Heart Ventricle Remodeling
14%
Noradrenalin
14%
Long Term Survival
14%
Heart Left Ventricle Failure
14%